Answers are grounded in this paper and cite their sources.
Sarcoidosis patients, especially those receiving immunosuppressive therapy (1), may have an increased risk for opportunistic infections including fungal infections and mycobacteria (1-3). Recent reports have suggested an increased rate of coronavirus disease 2019 (COVID-19) infection in sarcoidosis patients (4-7). These studies were usually retrospective and/or self-reported cases. We report the results of a prospective study performed in our sarcoidosis clinic comparing the rate of COVID-19 infection in sarcoidosis to cancer patients.
No takes yet. Share an insight, caveat, or question.
Baughman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: